Crispr Therapeutics Ag (CRSP)

Operating Income Growth

13.73%

Quarterly · Period ending:

CRSP logo

CRSP Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported13.73%
CRSP Quarterly Operating Income YoY % (-211.88% → 13.73%)
High-resolution chart · PNG

CRSP operating income growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Operating Income Growth — Quarterly
Period endingOperating Income Growth
13.7333%
12.246%
-139.6173%
-19.9119%
12.025%
-5.5745%
-192.8215%
16.8272%
-58.8482%
-118.0083%
152.8983%
27.4015%
48.0394%
63.3538%
9.7167%
-41.5517%
-124.0304%
-53.6296%
-35.2048%
-39.4485%
1,045.1325%
-55.6587%
-1,081.1618%
-166.3962%
-46.7526%
-51.965%
124.2836%
381.5241%
-47.4629%
-79.3644%
-4,753.0864%
-109.7242%
-75.0023%
-30.1437%
103.8404%
-61.3279%
-28.675%
-78.0295%
-108.0388%
-135.5692%
-356.7724%
-211.8844%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.